CN109485611A - A kind of preparation method of triazole derivatives - Google Patents
A kind of preparation method of triazole derivatives Download PDFInfo
- Publication number
- CN109485611A CN109485611A CN201811618082.0A CN201811618082A CN109485611A CN 109485611 A CN109485611 A CN 109485611A CN 201811618082 A CN201811618082 A CN 201811618082A CN 109485611 A CN109485611 A CN 109485611A
- Authority
- CN
- China
- Prior art keywords
- preparation
- triazole derivatives
- reaction
- added
- aminophenol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 36
- 229940042055 systemic antimycotics triazole derivative Drugs 0.000 title claims abstract description 22
- 238000006243 chemical reaction Methods 0.000 claims abstract description 77
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 claims abstract description 62
- 229910021595 Copper(I) iodide Inorganic materials 0.000 claims abstract description 27
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 claims abstract description 27
- 239000003054 catalyst Substances 0.000 claims abstract description 10
- 150000000475 acetylene derivatives Chemical class 0.000 claims abstract description 7
- 241001597008 Nomeidae Species 0.000 claims abstract description 6
- 239000002798 polar solvent Substances 0.000 claims abstract description 3
- 239000002994 raw material Substances 0.000 claims abstract description 3
- 238000007363 ring formation reaction Methods 0.000 claims abstract description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 81
- -1 substituted-phenyl Chemical group 0.000 claims description 25
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 claims description 10
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims description 10
- 229930192474 thiophene Natural products 0.000 claims description 7
- 125000001624 naphthyl group Chemical group 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- 150000003577 thiophenes Chemical class 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 5
- 239000000758 substrate Substances 0.000 abstract description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 75
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 42
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 33
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 25
- 239000012074 organic phase Substances 0.000 description 25
- 238000010898 silica gel chromatography Methods 0.000 description 25
- 239000002904 solvent Substances 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 25
- UEXCJVNBTNXOEH-UHFFFAOYSA-N Ethynylbenzene Chemical group C#CC1=CC=CC=C1 UEXCJVNBTNXOEH-UHFFFAOYSA-N 0.000 description 24
- 238000010791 quenching Methods 0.000 description 24
- 230000000171 quenching effect Effects 0.000 description 24
- 239000007787 solid Substances 0.000 description 24
- 238000005160 1H NMR spectroscopy Methods 0.000 description 21
- 238000012544 monitoring process Methods 0.000 description 20
- 235000019270 ammonium chloride Nutrition 0.000 description 11
- 230000006837 decompression Effects 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 6
- 238000000605 extraction Methods 0.000 description 5
- ICIWUVCWSCSTAQ-UHFFFAOYSA-M iodate Chemical compound [O-]I(=O)=O ICIWUVCWSCSTAQ-UHFFFAOYSA-M 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
- XQFARSXVMYNQRL-UHFFFAOYSA-N acetylene chlorobenzene Chemical group C#C.ClC1=CC=CC=C1 XQFARSXVMYNQRL-UHFFFAOYSA-N 0.000 description 3
- YJMNLPRMBFMFDL-UHFFFAOYSA-N n-diazo-2-methylbenzenesulfonamide Chemical compound CC1=CC=CC=C1S(=O)(=O)N=[N+]=[N-] YJMNLPRMBFMFDL-UHFFFAOYSA-N 0.000 description 3
- HQNSWBRZIOYGAW-UHFFFAOYSA-N 2-chloro-n,n-dimethylpyridin-4-amine Chemical compound CN(C)C1=CC=NC(Cl)=C1 HQNSWBRZIOYGAW-UHFFFAOYSA-N 0.000 description 2
- TZRXHJWUDPFEEY-UHFFFAOYSA-N Pentaerythritol Tetranitrate Chemical compound [O-][N+](=O)OCC(CO[N+]([O-])=O)(CO[N+]([O-])=O)CO[N+]([O-])=O TZRXHJWUDPFEEY-UHFFFAOYSA-N 0.000 description 2
- CRFJRGSTIQFTQW-UHFFFAOYSA-N acetylene fluorobenzene Chemical group C#C.FC1=CC=CC=C1 CRFJRGSTIQFTQW-UHFFFAOYSA-N 0.000 description 2
- 238000005660 chlorination reaction Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- 150000003852 triazoles Chemical class 0.000 description 2
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 1
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 description 1
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 1
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 1
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 1
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 1
- 150000000177 1,2,3-triazoles Chemical class 0.000 description 1
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 1
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 1
- ZASXCTCNZKFDTP-UHFFFAOYSA-N 1-ethynyl-3-methoxybenzene Chemical group COC1=CC=CC(C#C)=C1 ZASXCTCNZKFDTP-UHFFFAOYSA-N 0.000 description 1
- RENYIDZOAFFNHC-UHFFFAOYSA-N 1-ethynyl-3-methylbenzene Chemical group CC1=CC=CC(C#C)=C1 RENYIDZOAFFNHC-UHFFFAOYSA-N 0.000 description 1
- XTKBMZQCDBHHKY-UHFFFAOYSA-N 1-ethynyl-4-(trifluoromethyl)benzene Chemical group FC(F)(F)C1=CC=C(C#C)C=C1 XTKBMZQCDBHHKY-UHFFFAOYSA-N 0.000 description 1
- KBIAVTUACPKPFJ-UHFFFAOYSA-N 1-ethynyl-4-methoxybenzene Chemical group COC1=CC=C(C#C)C=C1 KBIAVTUACPKPFJ-UHFFFAOYSA-N 0.000 description 1
- KSZVOXHGCKKOLL-UHFFFAOYSA-N 4-Ethynyltoluene Chemical group CC1=CC=C(C#C)C=C1 KSZVOXHGCKKOLL-UHFFFAOYSA-N 0.000 description 1
- 229940126657 Compound 17 Drugs 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N N-phenyl amine Natural products NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 1
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 1
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 1
- QDJZBFLFHUMZBE-UHFFFAOYSA-N acetylene;bromobenzene Chemical group C#C.BrC1=CC=CC=C1 QDJZBFLFHUMZBE-UHFFFAOYSA-N 0.000 description 1
- 150000001345 alkine derivatives Chemical class 0.000 description 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 125000001309 chloro group Chemical class Cl* 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 229940125797 compound 12 Drugs 0.000 description 1
- 229940126543 compound 14 Drugs 0.000 description 1
- 229940125758 compound 15 Drugs 0.000 description 1
- 229940126142 compound 16 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940125810 compound 20 Drugs 0.000 description 1
- 229940126086 compound 21 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000006352 cycloaddition reaction Methods 0.000 description 1
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
- C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention discloses a kind of preparation methods of triazole derivatives, the described method includes: using arylsulfonyl azido derivant and acetylene-derivative as raw material, cuprous iodide and o-aminophenol are that triazole derivatives are prepared by cyclization under the conditions of aprotic polar solvent in catalyst.The preparation method reaction substrate universality of triazole derivatives of the present invention is wide, and reaction condition is mild, easy to operate, high income.
Description
Technical field
The invention belongs to organic synthesis fields, and in particular to a kind of preparation method of triazole derivatives.
Background technique
Triazole derivatives are shown as a kind of very valuable 5-member heterocyclic ring containing nitrogen skeleton due to its complex
Excellent optics, antiseptic property, are applied to the neighborhoods such as organic catalysis, material science extensively.In addition, triazole derivatives table
The good bioactivity revealed also has important purposes in pharmacy industry, pesticide.Therefore, the conjunction of triazole compound
It is had received widespread attention at application.
Till now, researcher has discovered that the synthetic method of many triazole compounds, but most of
The step of synthetic method, is cumbersome, and reaction condition is complicated, low yield.Therefore, it is necessary to which to research and develop a kind of reaction substrate universality wide,
Reaction condition mild, easy to operate, high income method is effectively synthesized triazole derivative compound.
Summary of the invention
The purpose of the present invention is to provide a kind of preparation method of triazole derivatives, reaction substrate universality is wide, instead
Answer mild condition, easy to operate, high income.
In order to achieve the above purpose, technical scheme is as follows:
A kind of preparation method of triazole derivatives, comprising the following steps:
Using arylsulfonyl azido derivant and acetylene-derivative as raw material, cuprous iodide and o-aminophenol are catalyst,
Under the conditions of aprotic polar solvent, triazole derivatives are prepared by cyclization;
Wherein, the general structure of the arylsulfonyl azido derivant is as follows:
Ar is selected from substituted aromatic base, and the aromatic radical includes but is not limited to phenyl, substituted-phenyl, naphthalene, substituted naphthyl, thiophene
Pheno base, substituted thiophene base;
The general structure of the acetylene-derivative is as follows:
R1Selected from alkyl, aromatic radical, the aromatic radical include but is not limited to phenyl, substituted-phenyl, naphthalene, substituted naphthyl,
Thienyl, substituted thiophene base;
The general structure of the triazole derivatives is as follows:
Preferably, the structure of the arylsulfonyl azido derivant is as follows in above-mentioned technical proposal:
Preferably, the structure of the acetylene-derivative is as follows in above-mentioned technical proposal:
Preferably, the reaction dissolvent is acetonitrile in above-mentioned technical proposal.
Preferably, the reaction temperature is room temperature in above-mentioned technical proposal.
Preferably, the additional amount of the catalyst o-aminophenol is 5%-20%, described to urge in above-mentioned technical proposal
The additional amount of agent cuprous iodide is 5%-20%.
Preferably, the additional amount of the catalyst o-aminophenol is 5%, the catalyst in above-mentioned technical proposal
It is 10% that the amount of cuprous iodide, which enters amount,.
According to the preparation method of above-mentioned triazole derivatives, the triazole that inventor has been synthetically prepared such as flowering structure is derivative
Object:
Compared with the prior art, the invention has the following beneficial effects: the present invention by copper be catalyzed aryl azide chemical combination object and
The method that alkynes carries out cycloaddition synthesizes 1,2,3- triazole compounds, and this method has reaction substrate universality wide, reacts item
The advantages that part is mild, easy to operate, high income.
Specific embodiment
The present invention is clearly and completely described below by specific embodiment, it is clear that described embodiment is only
It is a part of the embodiments of the present invention, instead of all the embodiments.Based on the embodiment of the present invention, this neighborhood ordinary skill people
Member's every other embodiment obtained, belongs to protection scope of the present invention.
The preparation of compound 1:
Embodiment 1
It will be to Methyl benzenesulfonyl nitrine (1.0mmol), phenylacetylene (1.1mmol), o-aminophenol (0.2mmol), iodate
Cuprous (0.1mmol), it is dissolved in 1mL acetonitrile, reacts at room temperature 3h, 2mL saturated ammonium chloride quenching reaction is added, water is added
Organic phase is collected in 30mL, methylene chloride 40mL × 3 extraction, and anhydrous sodium sulfate is dry, and vacuum rotary steam removes solvent, through silicagel column
Chromatography obtains white solid, yield 32%.
1H NMR (400MHz, CDCl3): δ 8.32 (s, 1H), 8.03 (d, J=8.4Hz, 2H), 7.82 (d, J=7.2Hz,
2H),7.45–7.38(m,5H),2.44(s,3H)。
Embodiment 2
It will be to Methyl benzenesulfonyl nitrine (1.0mmol), phenylacetylene (1.1mmol), o-aminophenol (0.1mmol), iodate
Cuprous (0.1mmol), it is dissolved in 1mL acetonitrile, reacts at room temperature 3h, 2mL saturated ammonium chloride quenching reaction is added, water is added
Organic phase is collected in 30mL, methylene chloride 40mL × 3 extraction, and anhydrous sodium sulfate is dry, and vacuum rotary steam removes solvent, through silicagel column
Chromatography obtains white solid, yield 38%.
Embodiment 3
It will be to Methyl benzenesulfonyl nitrine (1.0mmol), phenylacetylene (1.1mmol), o-aminophenol (0.05mmol), iodate
Cuprous (0.1mmol), it is dissolved in 1mL acetonitrile, reacts at room temperature 3h, 2mL saturated ammonium chloride quenching reaction is added, water is added
Organic phase is collected in 30mL, methylene chloride 40mL × 3 extraction, and anhydrous sodium sulfate is dry, and vacuum rotary steam removes solvent, through silicagel column
Chromatography obtains white solid, yield 75%.
Embodiment 4
It will be to Methyl benzenesulfonyl nitrine (1.0mmol), phenylacetylene (1.1mmol), o-aminophenol (0.05mmol), iodate
Cuprous (0.2mmol), it is dissolved in 1mL acetonitrile, reacts at room temperature 3h, 2mL saturated ammonium chloride quenching reaction is added, water is added
Organic phase is collected in 30mL, methylene chloride 40mL × 3 extraction, and anhydrous sodium sulfate is dry, and vacuum rotary steam removes solvent, through silicagel column
Chromatography obtains white solid, yield 60%.
Embodiment 5
It will be to Methyl benzenesulfonyl nitrine (1.0mmol), phenylacetylene (1.1mmol), o-aminophenol (0.05mmol), iodate
Cuprous (0.05mmol), it is dissolved in 1mL acetonitrile, reacts at room temperature 3h, 2mL saturated ammonium chloride quenching reaction is added, water is added
Organic phase is collected in 30mL, methylene chloride 40mL × 3 extraction, and anhydrous sodium sulfate is dry, and vacuum rotary steam removes solvent, through silicagel column
Chromatography obtains white solid, yield 30%.
The preparation of 6 compound 2 of embodiment
By 4- Methoxy-phenylacetylene (1mmol), o-aminophenol (0.05mmol), cuprous iodide (0.1mmol), to methyl
Benzenesulfonyl azide (1.0mmol) is dissolved in 1mL acetonitrile, reacts at room temperature 1h, and 2mL is added in contact plate monitoring reaction after completion of the reaction
Water 30mL is added in saturated ammonium chloride quenching reaction, and methylene chloride 40mL × 3 is extracted, and collects organic phase, and anhydrous sodium sulfate is dry,
Vacuum rotary steam removes solvent, separates to obtain white solid, yield 90% through silica gel column chromatography.
1H NMR (600MHz, CDCl3): δ 8.21 (s, 1H), 8.02 (d, J=8.4Hz, 2H), 7.75 (d, J=8.8Hz,
2H), 7.38 (d, J=8.4Hz, 2H), 6.95 (d, J=8.8Hz, 2H), 3.84 (s, 3H), 2.45 (s, 3H).
The preparation of 7 compound 3 of embodiment
By positive octyne (1mmol), o-aminophenol (0.05mmol), cuprous iodide (0.1mmol), p-toluene sulfonyt azide
(2mmol) is dissolved in 1mL acetonitrile, and for 24 hours, 2mL saturated ammonium chloride is added after completion of the reaction and quenches for contact plate monitoring reaction for room temperature reaction
It goes out reaction, water 30mL is added, methylene chloride 40mL × 3 is extracted, and collects organic phase, and anhydrous sodium sulfate is dry, and vacuum rotary steam removes
Solvent, through the isolated colourless transparent liquid yield 20% of silica gel column chromatography.
1H NMR (400MHz, CDCl3): δ 7.97 (d, J=8.4Hz, 2H), 7.83 (s, 1H), 7.36 (d, J=8.4Hz,
2H), 2.69 (t, J=8.0Hz, 2H), 2.44 (s, 3H), 1.65-1.62 (m, 2H), 1.31-1.25 (m, 6H), 0.86 (t, J=
7.2Hz,3H)。
The preparation of 8 compound 4 of embodiment
By 3- Methoxy-phenylacetylene (1.1mmol), o-aminophenol (0.05mmol), cuprous iodide (0.1mmol), to first
Benzenesulfonyl azide (1.0mmol) is dissolved in 1mL acetonitrile, reacts at room temperature 1h, and 2mL is added in contact plate monitoring reaction after completion of the reaction
Water 30mL is added in saturated ammonium chloride quenching reaction, and methylene chloride 40mL × 3 is extracted, and collects organic phase, and anhydrous sodium sulfate is dry,
Vacuum rotary steam removes solvent, through the isolated white solid 286mg of silica gel column chromatography, yield 87%.
1H NMR (600MHz, CDCl3): δ 8.30 (s, 1H), 8.02 (d, J=8.4Hz, 2H), 7.41-7.33 (m, 5H),
6.91(m,1H),3.85(s,3H),2.44(s,3H)。
The preparation of 9 compound 5 of embodiment
By 2- chlorobenzene acetylene (1.1mmol), o-aminophenol (0.05mmol), cuprous iodide (0.1mmol), to toluene sulphur
Acyl azide (1.0mmol) is dissolved in 1mL acetonitrile, reacts at room temperature 2h, and 2mL saturation is added in contact plate monitoring reaction after completion of the reaction
Water 30mL is added in ammonium chloride quenching reaction, and methylene chloride 40mL × 3 is extracted, and collects organic phase, and anhydrous sodium sulfate is dry, decompression
Revolving removes solvent, through the isolated white solid of silica gel column chromatography, yield 70%.
1H NMR (600MHz, CDCl3): δ 8.74 (s, 1H), 8.20 (dd, J=7.8Hz, 1.2Hz, 1H), 8.04 (d, J
=7.8Hz, 2H), 7.46 (d, J=7.8Hz, 1H), 7.40 (d, J=8.4Hz, 2H), 7.36 (t, J=7.8Hz, 1H), 7.30
(t, J=7.8Hz, 1H), 2.45 (s, 3H).
The preparation of 10 compound 6 of embodiment
By 3- chlorobenzene acetylene (1.1mmol), o-aminophenol (0.05mmol), cuprous iodide (0.1mmol), to toluene sulphur
Acyl azide (1.0mmol) is dissolved in 1mL acetonitrile, reacts at room temperature 1h, and 2mL saturation is added in contact plate monitoring reaction after completion of the reaction
Water 30mL is added in ammonium chloride quenching reaction, and methylene chloride 40mL × 3 is extracted, and collects organic phase, and anhydrous sodium sulfate is dry, decompression
Revolving removes solvent, through the isolated white solid of silica gel column chromatography, yield 75%.
1H NMR (400MHz, CDCl3): δ 8.33 (s, 1H), 8.03 (d, J=8.4Hz, 2H), 7.82 (s, 1H), 7.70
(dt, J=7.2,1.6Hz, 1H), 7.40 (m, 2H), 7.34 (m, 2H), 2.45 (s, 3H).
The preparation of 11 compound 7 of embodiment
By 4- fluorobenzene acetylene (1.1mmol), o-aminophenol (0.05mmol), cuprous iodide (0.1mmol), to toluene sulphur
Acyl azide (1.0mmol) is dissolved in 1mL acetonitrile, reacts at room temperature 1h, and 2mL saturation is added in contact plate monitoring reaction after completion of the reaction
Water 30mL is added in ammonium chloride quenching reaction, and methylene chloride 40mL × 3 is extracted, and collects organic phase, and anhydrous sodium sulfate is dry, decompression
Revolving removes solvent, through the isolated white solid of silica gel column chromatography, yield 75%.
1H NMR (600MHz, CDCl3): δ 8.27 (s, 1H), 8.03 (d, J=8.4Hz, 2H), 7.80 (dd, J=8.4,
5.4Hz, 2H), 7.39 (d, J=8.4Hz, 2H), 7.12 (t, J=9.0Hz, 2H), 2.45 (s, 3H).
The preparation of 12 compound 8 of embodiment
By 4- chlorobenzene acetylene (1.1mmol), o-aminophenol (0.05mmol), cuprous iodide (0.1mmol), to toluene sulphur
Acyl azide (1.0mmol) is dissolved in 1mL acetonitrile, reacts at room temperature 1h, and 2mL saturation is added in contact plate monitoring reaction after completion of the reaction
Water 30mL is added in ammonium chloride quenching reaction, and methylene chloride 40mL × 3 is extracted, and collects organic phase, and anhydrous sodium sulfate is dry, decompression
Revolving removes solvent, through the isolated white solid of silica gel column chromatography, yield 87%.
1H NMR (600MHz, CDCl3): δ 8.30 (s, 1H), 8.03 (d, J=8.4Hz, 2H), 7.76 (d, J=9.0Hz,
2H), 7.41 (dd, J=8.4 5.4Hz, 4H), 2.45 (s, 3H).
The preparation of 13 compound 9 of embodiment
By 3- fluorobenzene acetylene (1.1mmol), o-aminophenol (0.05mmol), cuprous iodide (0.1mmol), to toluene sulphur
Acyl azide (1.0mmol) is dissolved in 1mL acetonitrile, reacts at room temperature 1h, and 2mL saturation is added in contact plate monitoring reaction after completion of the reaction
Water 30mL is added in ammonium chloride quenching reaction, and methylene chloride 40mL × 3 is extracted, and collects organic phase, and anhydrous sodium sulfate is dry, decompression
Revolving removes solvent, through the isolated white solid of silica gel column chromatography, yield 70%.
1H NMR (400MHz, CDCl3): δ 8.32 (s, 1H), 8.03 (d, J=8.0Hz, 2H), 7.59-7.54 (m, 2H),
7.39 (d, J=8.0Hz, 3H), 7.06 (t, J=8.0Hz, 1H), 2.45 (s, 3H).
The preparation of 14 compound 10 of embodiment
By 4- bromobenzene acetylene (1.1mmol), o-aminophenol (0.05mmol), cuprous iodide (0.1mmol), to toluene sulphur
Acyl azide (1.0mmol) is dissolved in 1mL acetonitrile, reacts at room temperature 1h, and 2mL saturation is added in contact plate monitoring reaction after completion of the reaction
Water 30mL is added in ammonium chloride quenching reaction, and methylene chloride 40mL × 3 is extracted, and collects organic phase, and anhydrous sodium sulfate is dry, decompression
Revolving removes solvent, through the isolated white solid of silica gel column chromatography, yield 85%.
1H NMR (600MHz, CDCl3): δ 8.31 (s, 1H), 8.02 (d, J=8.4Hz, 2H), 7.70 (d, J=8.4Hz,
2H), 7.56 (d, J=8.4Hz, 2H), 7.39 (d, J=8.4Hz, 2H), 2.45 (s, 3H).
The preparation of 15 compound 11 of embodiment
By 4- trifluoromethyl phenylacetylene (1.1mmol), o-aminophenol (0.05mmol), cuprous iodide (0.1mmol), right
Tosyl nitrine (1.0mmol) is dissolved in 1mL acetonitrile, reacts at room temperature 12h, and contact plate monitoring reaction is added after completion of the reaction
Water 30mL is added in 2mL saturated ammonium chloride quenching reaction, and methylene chloride 40mL × 3 is extracted, and collects organic phase, and anhydrous sodium sulfate is dry
Dry, vacuum rotary steam removes solvent, through the isolated white solid of silica gel column chromatography, yield 40%.
1H NMR (400MHz, CDCl3): δ 8.40 (s, 1H), 8.04 (d, J=8.4Hz, 2H), 7.95 (d, J=8.1Hz,
2H), 7.69 (d, J=8.4Hz, 2H), 7.41 (d, J=8.2Hz, 2H), 2.46 (s, 3H).
The preparation of 16 compound 12 of embodiment
By 4- methyl phenylacetylene (1.1mmol), o-aminophenol (0.05mmol), cuprous iodide (0.1mmol), to toluene
Sulfonyl azide (1.0mmol) is dissolved in 1mL acetonitrile, reacts at room temperature 1h, and it is full that 2mL is added in contact plate monitoring reaction after completion of the reaction
With ammonium chloride quenching reaction, water 30mL is added, methylene chloride 40mL × 3 is extracted, and collects organic phase, and anhydrous sodium sulfate is dry, subtracts
Pressure revolving removes solvent, through the isolated white solid of silica gel column chromatography, yield 90%.
1H NMR (400MHz, CDCl3): δ 8.26 (s, 1H), 8.02 (d, J=8.0Hz, 2H), 7.71 (d, J=7.6Hz,
2H), 7.39 (d, J=8.4Hz, 2H), 7.23 (d, J=8.0Hz, 2H), 2.45 (s, 3H), 2.38 (s, 3H).
The preparation of 17 compound 13 of embodiment
By 3- thiophene acetylene (1.1mmol), o-aminophenol (0.05mmol), cuprous iodide (0.1mmol), to toluene sulphur
Acyl azide (1.0mmol) is dissolved in 1mL acetonitrile, reacts at room temperature 1h, and 2mL saturation is added in contact plate monitoring reaction after completion of the reaction
Water 30mL is added in ammonium chloride quenching reaction, and methylene chloride 40mL × 3 is extracted, and collects organic phase, and anhydrous sodium sulfate is dry, decompression
Revolving removes solvent, through the isolated white solid of silica gel column chromatography, yield 70%.
1H NMR (400MHz, CDCl3): δ 8.20 (s, 1H), 8.01 (d, J=8.0Hz, 2H), 7.75 (s, 1H), 7.40-
7.37(m,4H),2.44(s,3H)。
The preparation of 18 compound 14 of embodiment
By 3- methyl phenylacetylene (1.1mmol), o-aminophenol (0.05mmol), cuprous iodide (0.1mmol), to toluene
Sulfonyl azide (1.0mmol) is dissolved in 1mL acetonitrile, reacts at room temperature 1h, and it is full that 2mL is added in contact plate monitoring reaction after completion of the reaction
With ammonium chloride quenching reaction, water 30mL is added, methylene chloride 40mL × 3 is extracted, and collects organic phase, and anhydrous sodium sulfate is dry, subtracts
Pressure revolving removes solvent, through the isolated white solid of silica gel column chromatography, yield 89%.
1H NMR (600MHz, CDCl3): δ 8.29 (s, 1H), 8.02 (d, J=8.4Hz, 2H), 7.66 (s, 1H), 7.60
(d, J=7.8Hz, 1H), 7.39 (d, J=8.4Hz, 2H), 7.31 (t, J=7.8Hz, 1H), 7.18 (d, J=7.8Hz, 1H),
2.45(s,3H),2.39(s,3H)。
The preparation of 19 compound 15 of embodiment
By phenylacetylene (1.1mmol), o-aminophenol (0.05mmol), cuprous iodide (0.1mmol), to methoxybenzene sulphur
Acyl azide (1.0mmol) is dissolved in 1mL acetonitrile, reacts at room temperature 1h, and 2mL saturation is added in contact plate monitoring reaction after completion of the reaction
Water 30mL is added in ammonium chloride quenching reaction, and methylene chloride 40mL × 3 is extracted, and collects organic phase, and anhydrous sodium sulfate is dry, decompression
Revolving removes solvent, through the isolated white solid of silica gel column chromatography, yield 85%.
1H NMR (400MHz, CDCl3): δ 8.31 (s, 1H), 8.08 (d, J=9.2Hz, 2H), 7.82 (d, J=6.8Hz,
2H), 7.43 (t, J=7.2Hz, 2H), 7.37 (d, J=7.2Hz, 1H), 7.03 (d, J=9.2Hz, 2H), 3.88 (s, 3H).
The preparation of 20 compound 16 of embodiment
By phenylacetylene (1.1mmol), o-aminophenol (0.05mmol), cuprous iodide (0.1mmol), o-methyl-benzene sulphonyl
Nitrine (1.0mmol) is dissolved in 1mL acetonitrile, reacts at room temperature 1h, and 2mL is added after completion of the reaction and is saturated chlorine for contact plate monitoring reaction
Change ammonium quenching reaction, water 30mL is added, methylene chloride 40mL × 3 is extracted, and collects organic phase, and anhydrous sodium sulfate is dry, decompression rotation
Solvent is evaporated off, through the isolated white solid of silica gel column chromatography, yield 75%.
1H NMR (600MHz, CDCl3): δ 8.36 (s, 1H), 8.25 (d, J=7.8Hz, 1H), 7.84 (d, J=7.2Hz,
2H), 7.61 (t, J=7.2Hz, 1H), 7.46-7.43 (m, 3H), 7.38 (q, J=13.8 7.2Hz, 2H), 2.70 (s, 3H).
The preparation of 21 compound 17 of embodiment
Phenylacetylene (1.1mmol), adjacent aminobenzene (0.05mmol), cuprous iodide (0.1mmol), Methyl benzenesulfonyl is folded
Nitrogen (1.0mmol) is dissolved in 1mL acetonitrile, reacts at room temperature 1h, and 2mL is added after completion of the reaction and is saturated chlorination for contact plate monitoring reaction
Water 30mL is added in ammonium quenching reaction, and methylene chloride 40mL × 3 is extracted, and collects organic phase, anhydrous sodium sulfate is dry, vacuum rotary steam
Solvent is removed, through the isolated white solid of silica gel column chromatography, yield 80%.
1H NMR (600MHz, CDCl3): δ 8.33 (s, 1H), 7.95-7.93 (d, J=12.0Hz 2H), 7.83 (d, J=
7.8Hz, 2H), 7.51 (d, J=7.8Hz, 1H), 7.47 (t, J=7.8Hz, 1H), 7.43 (t, J=7.8Hz, 2H), 7.37 (t,
J=7.2Hz, 1H), 2.44 (s, 3H).
The preparation of 22 compound 18 of embodiment
Phenylacetylene (1.1mmol), o-aminophenol (0.05mmol), cuprous iodide (0.1mmol), 2- thiophenesulfonyl is folded
Nitrogen (1.0mmol) is dissolved in 1mL acetonitrile, reacts at room temperature 3h, and 2mL is added after completion of the reaction and is saturated chlorination for contact plate monitoring reaction
Water 30mL is added in ammonium quenching reaction, and methylene chloride 40mL × 3 is extracted, and collects organic phase, anhydrous sodium sulfate is dry, vacuum rotary steam
Solvent is removed, through the isolated white solid of silica gel column chromatography, yield 70%.
1H NMR (600MHz, CDCl3): δ 8.33 (s, 1H), 8.03 (m, 1H), 7.86-7.84 (m, 3H), 7.45 (t, J
=7.2Hz, 2H), 7.39 (t, J=7.8Hz, 1H), 7.20 (t, J=4.2Hz, 1H).
The preparation of 23 compound 19 of embodiment
By phenylacetylene (1.1mmol), o-aminophenol (0.05mmol), cuprous iodide (0.1mmol), 1- naphthalene sulfonyl nitrine
(1.0mmol) is dissolved in 1mL acetonitrile, reacts at room temperature 3h, and 2mL saturated ammonium chloride is added in contact plate monitoring reaction after completion of the reaction
Water 30mL is added in quenching reaction, and methylene chloride 40mL × 3 is extracted, and collects organic phase, and anhydrous sodium sulfate is dry, and vacuum rotary steam removes
Solvent is removed, through the isolated white solid of silica gel column chromatography, yield 60%.
1H NMR (600MHz, CDCl3) δ 8.88 (d, J=8.4Hz, 1H), 8.65 (d, J=7.8Hz, 1H), 8.41 (s,
1H), 8.23 (d, J=7.8Hz, 1H), 7.96 (d, J=7.8Hz, 1H), 7.80 (d, J=7.2Hz, 2H), 7.75 (t, J=
7.8Hz, 1H), 7.67 (t, J=7.8Hz, 1H), 7.63 (t, J=7.8Hz, 1H), 7.42 (t, J=7.8Hz, 2H), 7.36 (t,
J=7.8Hz, 1H).
The preparation of 24 compound 20 of embodiment
By phenylacetylene (1.1mmol), o-aminophenol (0.05mmol), cuprous iodide (0.1mmol), benzenesulfonyl azide
(1.0mmol) is dissolved in 1mL acetonitrile, reacts at room temperature 1h, and 2mL saturated ammonium chloride is added in contact plate monitoring reaction after completion of the reaction
Water 30mL is added in quenching reaction, and methylene chloride 40mL × 3 is extracted, and collects organic phase, and anhydrous sodium sulfate is dry, and vacuum rotary steam removes
Solvent is removed, separates to obtain white solid, yield 85% through silica gel column chromatography.
1H NMR (400MHz, CDCl3): δ 8.33 (s, 1H), 8.16 (d, J=8.4Hz, 2H), 7.83 (d, J=6.8Hz,
2H), 7.73 (t, J=7.6Hz, 1H), 7.61 (t, J=8.0Hz, 2H), 7.51-7.32 (m, 3H).
The preparation of 25 compound 21 of embodiment
By phenylacetylene (1.1mmol), o-aminophenol (0.05mmol), cuprous iodide (0.1mmol), to Ethyl formate benzene
Sulfonyl azide (1.0mmol) is dissolved in 1mL acetonitrile, reacts at room temperature 1h, and it is full that 2mL is added in contact plate monitoring reaction after completion of the reaction
With ammonium chloride quenching reaction, water 30mL is added, methylene chloride 40mL × 3 is extracted, and collects organic phase, and anhydrous sodium sulfate is dry, subtracts
Pressure revolving removes solvent, through the isolated white solid of silica gel column chromatography, yield 41%.
1H NMR (400MHz, CDCl3): δ 8.34 (s, 1H), 8.26-8.21 (m, 4H), 7.82 (d, J=6.8Hz, 2H),
7.46-7.38 (m, 3H), 4.41 (q, J=7.2Hz, 2H), 1.40 (t, J=7.2Hz, 3H).
The foregoing is merely illustrative of the preferred embodiments of the present invention, is not intended to limit the invention, all in essence of the invention
Within mind and principle, all any modification, equivalent substitution, improvement and etc. be should all be included in the protection scope of the present invention.
Claims (7)
1. a kind of preparation method of triazole derivatives, which comprises the following steps:
Using arylsulfonyl azido derivant and acetylene-derivative as raw material, cuprous iodide and o-aminophenol are catalyst, non-
Under the conditions of proton polar solvent, triazole derivatives are prepared by cyclization;
Wherein, the general structure of the arylsulfonyl azido derivant is as follows:
Ar is selected from substituted aromatic base, and the aromatic radical includes but is not limited to phenyl, substituted-phenyl, naphthalene, substituted naphthyl, thiophene
Base, substituted thiophene base;
The general structure of the acetylene-derivative is as follows:
R1Selected from alkyl, aromatic radical, the aromatic radical includes but is not limited to phenyl, substituted-phenyl, naphthalene, substituted naphthyl, thiophene
Base, substituted thiophene base;
The general structure of the triazole derivatives is as follows:
2. the preparation method of triazole derivatives as described in claim 1, which is characterized in that the arylsulfonyl nitrine is derivative
The structure of object is as follows:
3. the preparation method of triazole derivatives as described in claim 1, which is characterized in that the structure of the acetylene-derivative
It is as follows:
4. the preparation method of triazole derivatives as described in claim 1, which is characterized in that the reaction dissolvent is acetonitrile.
5. the preparation method of triazole derivatives as described in claim 1, which is characterized in that the reaction temperature is room temperature.
6. the preparation method of triazole derivatives as described in claim 1, which is characterized in that the catalyst o-aminophenol
Additional amount be 5%-20%, the additional amount of the catalyst cuprous iodide is 5%-20%.
7. the preparation method of triazole derivatives as described in claim 1, which is characterized in that the catalyst o-aminophenol
Additional amount be 5%, the amount of the catalyst cuprous iodide enter amount be 10%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811618082.0A CN109485611A (en) | 2018-12-28 | 2018-12-28 | A kind of preparation method of triazole derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811618082.0A CN109485611A (en) | 2018-12-28 | 2018-12-28 | A kind of preparation method of triazole derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109485611A true CN109485611A (en) | 2019-03-19 |
Family
ID=65712815
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811618082.0A Pending CN109485611A (en) | 2018-12-28 | 2018-12-28 | A kind of preparation method of triazole derivatives |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109485611A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111170955A (en) * | 2020-01-08 | 2020-05-19 | 河南师范大学 | Green preparation method of 2H-1,2, 3-triazole compound |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2899192A1 (en) * | 2014-01-24 | 2015-07-29 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Diazabicyclo[4.3.1]decane derivatives for treatment of psychiatric disorders |
CN106632285A (en) * | 2016-11-23 | 2017-05-10 | 河南师范大学 | Method for synthesizing zidovudine-1,2,3-triazole compound |
-
2018
- 2018-12-28 CN CN201811618082.0A patent/CN109485611A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2899192A1 (en) * | 2014-01-24 | 2015-07-29 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Diazabicyclo[4.3.1]decane derivatives for treatment of psychiatric disorders |
CN106632285A (en) * | 2016-11-23 | 2017-05-10 | 河南师范大学 | Method for synthesizing zidovudine-1,2,3-triazole compound |
Non-Patent Citations (2)
Title |
---|
MEI-HUA SHEN等: "Stereoselective Construction of Bridgedtrans-aza-Bicyclo[7/6,3/2,1]alkenyl Imines through Ring Expansion aza-Cope Rearrangement", 《ORG. LETT.》 * |
YANTAO LIU等: "Highly controlling selectivity of copper(I)-catalyzed azide/alkyne cycloaddition (CuAAC) between sulfonyl azids and normal alkynes or propynoates", 《TETRAHEDRON》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111170955A (en) * | 2020-01-08 | 2020-05-19 | 河南师范大学 | Green preparation method of 2H-1,2, 3-triazole compound |
CN111170955B (en) * | 2020-01-08 | 2023-04-07 | 河南师范大学 | Green preparation method of 2H-1,2,3-triazole compound |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2736894B1 (en) | Method for producing benzo[b] thiophene compounds | |
CN108047107B (en) | The preparation method of diphenyl disenenide ether compound | |
CN105175328B (en) | It is a kind of using aromatic amine, aromatic aldehyde, ketone synthesis of quinoline derivatives method | |
EP2630131B1 (en) | Process for obtaining dronedarone | |
CN107098834A (en) | A kind of preparation method of aromatic sulfinic acids class compound | |
Palomba et al. | Synthesis of Spirooxindole Oxetanes Through a Domino Reaction of 3‐Hydroxyoxindoles and Phenyl Vinyl Selenone | |
CN109485611A (en) | A kind of preparation method of triazole derivatives | |
CN110606850A (en) | 3-benzo [4,5] imidazo [1,2-a ] pyrazine-1-amine compound and preparation method and application thereof | |
CN103304466A (en) | Synthetic method of 3-alkyl-substituted indole compound | |
Gai et al. | The intramolecular 5-exo, 7-endo-dig transition metal-free cyclization sequence of (2-alkynylphenyl) benzyl ethers: synthesis of seven-membered fused benzo [b] furans | |
WO2016125845A1 (en) | Cross-coupling method, and method for producing organic compound using said cross-coupling method | |
CN105566235B (en) | The method of the substep synthesis triazoles of NH 1,2,3 is catalyzed using aluminium salt | |
CN110511193A (en) | A kind of α -one thioamide analog compound and its synthetic method | |
CN113105401B (en) | 1, 2, 3-triazole derivative and preparation method and application thereof | |
CN105198806B (en) | A kind of method using aromatic amine, diketone synthesis of quinoline derivatives | |
CN104557500A (en) | Method for synthesizing alpha-alkyl ketone | |
Tang et al. | Metal‐Free Cascade 1, 4‐Conjugate Addition/Selective Annulation Strategy for Divergent Synthesis of Polysubstituted Imidazoles and 4‐Alkenylquinazolines | |
CN105801464B (en) | Pyrrole amides class compound and preparation method thereof and purposes | |
CN105693778A (en) | N-methoxyl formamide-orientated method for synthesizing ferrocene and pyridone derivative | |
CN107417583B (en) | Utilize the method for non-metallic catalyst selectivity synthesis allyl sulfone compound | |
CN107082763A (en) | A kind of method for synthesizing indazole ketone compounds | |
CA1046072A (en) | 5-5-(4-chlorophenyl)-2-furanyl dihydro-2(3h)-furanone | |
CN105732597B (en) | A kind of midbody compound and the preparation method and application thereof preparing pyrrole amides class compound | |
CN106146417B (en) | A method of 4- aryl-NH-1,2,3- triazole is prepared using aldehyde sodium bisulfite adduct | |
WO2017209294A1 (en) | Method for producing sulfonimidized aromatic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190319 |